Fundraising Fox

Centenara Labs

3 known investors

Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan. It works with a global team drawn from medical and scientific institutions to develop longevity drugs and related technologies.

BiotechHealthtechLongevity

Founders & leadership

CAChristian Angermayer
Christian Angermayerin𝕏FounderFounder and Chairman of the Board at atai Life Sciences

Investors Β· 3

Catalio Capital Management, LPNew York
Korify Capital
P53 InvestStavanger

Competitors Β· 1

by search overlap
Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Centenara Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Rejuveron Life Sciences rejuvenates as Centenara Labs | Fierce Pharmafiercepharma.com Β· Sep 2024Centenara Labs - p53 Investp53.no Β· Nov 2021

Frequently asked questions

What does Centenara Labs do?
Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan. It works with a global team drawn from medical and scientific institutions to develop longevity drugs and related technologies.
Who founded Centenara Labs?
Centenara Labs was founded by Christian Angermayer.
Who are Centenara Labs's investors?
Centenara Labs's investors include Catalio Capital Management, LP, Korify Capital, P53 Invest.